A Randomized, Double-Blind Efficacy and Safety Study of PF-05280586 (a Potential Rituximab Biosimilar) Compared with Rituximab Reference Product (MabThera®) in Subjects with Previously Untreated CD20-Positive, Low Tumor Burden Follicular Lymphoma (LTB-FL) - Sharman, Jeff; Liberati, Anna Marina; Santucci Silva, Rodrigo; Aurer, Igor; Robbins, Jeffery; Rosenberg, Julie Ann; Khan, Tahira; Alcasid, Ann (Blood, 2018)